Q: current thoughts about ZCL, now under $9.00?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: A while ago you answered a question re. companies with large inside ownership. You gave a list. I am unable to find the answer now can you repeat the list please.
Thank You 5I
Thank You 5I
Q: G'day:
Trading for this stock has been halted.
Why? When will it commence trading again?
I own this stock and want to sell it.
Like many subscribers, I greatly appreciate your services. Thank you.
Greetings, Klaus
Trading for this stock has been halted.
Why? When will it commence trading again?
I own this stock and want to sell it.
Like many subscribers, I greatly appreciate your services. Thank you.
Greetings, Klaus
Q: I am a multi-year owner of this company. I read your recent report and was surprised to see that Mawer owned such a large position (must have missed it previously). I consider them one of the better money managers out there so on the one hand, I consider their position a plus. But it does make wonder about a few things.
Is it common for a fund company to own such a significant position in a small cap name? CXI is a very thinly traded stock so how does Mawer exit other than through a takeover since selling out their position would likely decimate the stock price? Would this have been their plan all along or have they accumulated this position over the years suggesting they are believing in the story more and more? Would Mawer be an active or at least "very interested", party as to how the company is run? In sum, does having Mawer own so much change or affect how we should view this stock?
Appreciate your insight.
Paul F.
Is it common for a fund company to own such a significant position in a small cap name? CXI is a very thinly traded stock so how does Mawer exit other than through a takeover since selling out their position would likely decimate the stock price? Would this have been their plan all along or have they accumulated this position over the years suggesting they are believing in the story more and more? Would Mawer be an active or at least "very interested", party as to how the company is run? In sum, does having Mawer own so much change or affect how we should view this stock?
Appreciate your insight.
Paul F.
Q: LIB-L Trying to find late opportunities in the cannabis space. Any thoughts on Liberty?
Q: Is it better to sell ENF and reinvest elsewhere or just ride out the ENB, ENF consolidation?
Q: I have 6% of portflio in ENB. Will it be better to sell 50% of ENB and buy KEY for better risk management and capital appreciation. Although ENB pays 2% more dividend.
OR
Will it be prudent to sell half or all of ENB and buy CSU?
Thank you, kam
OR
Will it be prudent to sell half or all of ENB and buy CSU?
Thank you, kam
Q: I'm way under water on these three stocks. I've held them for more than a year. Is there any point at this time to continue to hold any of them or should I just cut my losses and move on? Any suggestions for better (actual) growth in the same sectors?
Q: Is it time to revisit Intrinsyc? The Company had a great Q4, followed up by a strong Q1 with a positive outlook for Q2. Including today they have announced a string of large orders which indicates continued momentum in their business.
Q: What are you thoughts on this company as an investment, and is it only available on the London exchange, or can it be purchased on the US OTCBB? Ocado
Q: When will you be updating the model portfolios for May 2018? Ernie
Q: Simply, what separates TRP from ENB as far as your recommendation to own it goes?
Future growth, dividends?
Thx KC
Future growth, dividends?
Thx KC
Q: AQA was up on Friday and today is up another 2.5 pennies. If this keeps up I may even break even one day! I have checked my online brokers news feeds which don't show anything noteworthy. Do your sources show any reason for the strength?
Thanks,
Jim
Thanks,
Jim
Q: I am holding a position in this company waiting to see what the acquisition of Cardiome Pharma will look like - meaning will this put CPH on a path to higher earning. However the stock price is finding new 52 week lows. Would your advice be sell now or give them a quarter or two to see what this acquisition is going to look like?
Q: I went on holiday and forgot to buy it, so missed the run up in this stock. Do you think its still worth buying here. My timing on stocks is not usually great. Buy half now and half on a pullback?
Q: Both on the Toronto stock Exchange but TCN invests more in the US.
Please compare the two.
An investor heading into retirement.
Please compare the two.
An investor heading into retirement.
Q: What is your view on this precious metals royalty stock for growth or income
Q: hi Peter know you do not follow US companies but wondered if you had any general thoughts about the recent further investment by Fairfax in SSW(now up to 1 billion USD). the shares trade at under 14X and with a div of .50 cents yield 5.59%. the CEO is a former senior executive with Berkshire Hathaway SSW is using the capital infusion to buy or create strategic partnerships with competitor companies not sure about debt/equity thanks for your input Richard.
Q: ZYME has dropped 12% rather abruptly this morning but I can't find any relevant news on-line. Do you know of any particular problems?
Thanks,
John
Thanks,
John
Q: There is competition coming from Japan from a company called Miniso.
Do you think this will hurt DOL?
Will it drop DOL's sales by 10% or so or it will be negligible.
Thanks
Do you think this will hurt DOL?
Will it drop DOL's sales by 10% or so or it will be negligible.
Thanks